Orford Keith 4
4 · Calithera Biosciences, Inc. · Filed Nov 12, 2021
Insider Transaction Report
Form 4
Orford Keith
SR. VP, CLINICAL DEVELOPMENT
Transactions
- Sale
Common Stock
2021-11-10$0.86/sh−30,000$25,695→ 114,284 total - Sale
Common Stock
2021-11-11$0.88/sh−48,190$42,407→ 66,094 total